IIL gets regulatory nod for measles-rubella vaccine
The MR vaccine was developed by Hyderabad-based IIL in exclusive partnership with Vietnam's state owned Center for Research and Production of Vaccines and Biologicals, also called Polyvac, Vietnam.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Measles | Measles Vaccine | Partnerships | Pharmaceuticals | Rubella | Rubella Vaccine | Vaccines | Vietnam Health